SAN DIEGO, CA--(Marketwire - July 9, 2007) - Protein Polymer Technologies, Inc. (OTCBB: PPTI) a biotechnology device company that is a pioneer in protein design and synthesis, announced today that it has entered into an agreement with a multinational medical device company. According to the terms of the agreement, PPTI will provide genetically engineered protein polymer biomaterials for use in drug delivery applications. “This latest agreement underscores PPTI’s ability to develop innovative and pioneering biomaterials which complement the extensive array of life enhancing devices and products produced by our corporate partners,” said William N. Plamondon, Chairman and Chief Executive Officer of PPTI.
